Trials / Completed
CompletedNCT00159705
Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
A Randomized Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 276 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Trial will evaluate the efficacy and safety of pregabalin in the treatment of subjects with neuropathic pain associated with lumbo-sacral radiculopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin |
Timeline
- Start date
- 2005-04-01
- Completion
- 2007-06-01
- First posted
- 2005-09-12
- Last updated
- 2021-01-25
Locations
52 sites across 8 countries: United States, Belgium, Canada, Germany, Italy, Spain, Sweden, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00159705. Inclusion in this directory is not an endorsement.